[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
WSJ: NEJM Misses Vioxx Warning Signs
- To: <liblicense-l@lists.yale.edu>
- Subject: WSJ: NEJM Misses Vioxx Warning Signs
- From: "Masterson, Michele" <Michele_Masterson@simbanet.com>
- Date: Mon, 15 May 2006 21:02:33 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
I am writing an article an article concerning today's story in the WSJ, "Bitter Pill: How the New England Journal Missed Warning Signs on Vioxx." I would like to get input/reactions from STM societies/publishers as soon as possible. Please feel free to e-mail me privately if you do not want your posts stated publicly. I am deadline, so I would appreciate responses as soon as possible, thanks. The article reports some very troubling news, alleging that the "medical weekly waited years to report flaws in article that praised pain drug." In a summary, a blog on the Pharma Marketing News Web site stated: We were hoodwinked! http://pharmamkting.blogspot.com/2006/05/we-were-hoodwinked.html michele_masterson@simbanet.com Michele Masterson Editor/Analyst Simba Information www.simbanet.com
- Prev by Date: RE: Does BMC's business model conflict with Editorial Independence?
- Next by Date: RE: Does BMC's business model conflict with Editorial Independence?
- Previous by thread: The Goodman-Banks thread
- Next by thread: Re: WSJ: NEJM Misses Vioxx Warning Signs
- Index(es):